Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction

Myeongjin Jeon1,2, Daeun You1,2, Soo Youn Bae1

  • 1Department of Surgery, Samsung Medical Center, Gangnam-gu, Seoul 06351, Korea.

Oncotarget
|September 9, 2017
PubMed

Insights

EGFR and HER2 dimerization promotes breast cancer invasion and metastasis. This process involves increased alpha-smooth muscle actin (ACTA2) expression via the JAK2/STAT1 pathway, leading to poor patient survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Epidermal Growth Factor Receptor (EGFR) and Human Epidermal growth factor Receptor 2 (HER2) dimerization is linked to poor breast cancer prognosis, including tumor growth and invasion.
  • The precise molecular mechanisms driving these outcomes post-dimerization in breast cancer remain incompletely understood.

Purpose of the Study:

  • To elucidate the signaling pathways and molecular events following EGFR and HER2 dimerization in breast cancer.
  • To investigate the role of alpha-smooth muscle actin (ACTA2) and signal transducer and activator of transcription 1 (STAT1) in HER2-driven breast cancer progression.

Main Methods:

  • Overexpression and knockdown (siRNA, shRNA) of HER2, ACTA2, and STAT1 in EGFR-positive breast cancer cell lines (MDA-MB231 HER2, 4T1).
  • Inhibition of STAT1 and JAK2 signaling pathways using fludarabine and AG490, respectively.
  • Analysis of ACTA2 and STAT1 expression in patient tumor samples and correlation with relapse-free survival.
  • Assessment of cell motility and lung metastasis in mouse models.

Main Results:

  • HER2 overexpression significantly increased ACTA2 and STAT1 expression in breast cancer cells, while HER2 knockdown decreased ACTA2.
  • ACTA2 expression was dependent on JAK2/STAT1 signaling, as indicated by inhibition with fludarabine and AG490, and enhancement with STAT1 overexpression.
  • Elevated ACTA2, STAT1, and HER2 levels correlated with decreased relapse-free survival in high-risk breast cancer patients.
  • ACTA2 knockdown suppressed cancer cell motility and reduced lung metastasis in vivo.

Conclusions:

  • EGFR and HER2 dimerization induces ACTA2 expression through the JAK2/STAT1 signaling pathway.
  • Aberrant ACTA2 expression driven by HER2 signaling accelerates breast cancer cell invasiveness and metastasis.
  • Targeting the JAK2/STAT1/ACTA2 axis may offer therapeutic strategies for HER2-positive breast cancer.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
19.8K
Actin Polymerization and Cell Motility01:13

Actin Polymerization and Cell Motility

Actin is a family of globular proteins that are highly abundant in eukaryotic cells. It makes up approximately 1-5% of total cell protein concentration. Actin monomers polymerize to form a complex network of polarized filaments, the actin cytoskeleton, that plays a crucial role in many cellular processes, including cell motility, division, endocytosis, and metastasis of cancer cells.
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate....
6.9K